| Insideraktier | 9.336.049 shares |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Netto antal insidere, der køber (rang)
N/A
Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).
Procent af float købt af insidere (rangering)
N/A
Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.
Insiderhandelsdiagram
Astria Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ATXS / Astria Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ATXS / Astria Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-23 | 2026-01-23 | 4 | Violin Jonathan | ATXS | Common Stock | D | -263.321 | 0 | ||||||
| 2026-01-23 | 2026-01-23 | 4 | Milne Jill C. | ATXS | Common Stock | D | -4.377 | 0 | ||||||
| 2026-01-23 | 2026-01-23 | 4 | Komjathy Andrew | ATXS | Common Stock | I | -45 | 0 | ||||||
| 2026-01-23 | 2026-01-23 | 4 | Komjathy Andrew | ATXS | Common Stock | I | -45 | 0 | ||||||
| 2026-01-23 | 2026-01-23 | 4 | Komjathy Andrew | ATXS | Common Stock | D | -10 | 0 | ||||||
| 2024-04-03 | 2024-04-01 | 4 | Morabito Christopher | ATXS | Common Stock | D | 13,5939 | -10.000 | -136 | 0 | ||||
| 2024-04-03 | 2024-04-01 | 4 | Morabito Christopher | ATXS | Common Stock | D | 3,8700 | 10.000 | 39 | 10.000 | ||||
| 2024-02-05 | 2024-02-01 | 4 | PERCEPTIVE ADVISORS LLC | ATXS | Common Stock | I | 12,0900 | 2.481.350 | 30.000 | 4.873.721 | ||||
| 2024-01-30 | 2024-01-29 | 4 | Morabito Christopher | ATXS | Common Stock | D | 11,1470 | -9.200 | -103 | 0 | ||||
| 2024-01-30 | 2024-01-29 | 4 | Morabito Christopher | ATXS | Common Stock | D | 3,8700 | 9.200 | 36 | 9.200 | ||||
| 2024-01-30 | 2024-01-26 | 4 | Morabito Christopher | ATXS | Common Stock | D | 11,0150 | -800 | -9 | 0 | ||||
| 2024-01-30 | 2024-01-26 | 4 | Morabito Christopher | ATXS | Common Stock | D | 3,8700 | 800 | 3 | 800 | ||||
| 2023-12-22 | 2023-12-21 | 4 | PERCEPTIVE ADVISORS LLC | ATXS | Common Stock | I | 6,2000 | 740.000 | 4.588 | 2.392.371 | ||||
| 2023-10-18 | 2023-10-16 | 4 | PERCEPTIVE ADVISORS LLC | ATXS | Common Stock | I | 6,5140 | 460.546 | 3.000 | 1.611.699 | ||||
| 2023-10-18 | 2023-10-16 | 4 | PERCEPTIVE ADVISORS LLC | ATXS | Common Stock | I | 6,5140 | 614.062 | 4.000 | 1.652.371 | ||||
| 2022-12-21 | 2022-12-19 | 4 | PERCEPTIVE ADVISORS LLC | ATXS | Common Stock | I | 11,0100 | 908.265 | 10.000 | 1.038.309 | ||||
| 2022-03-03 | 2022-03-01 | 4 | Harshbarger Benjamin | ATXS | Stock Option (right to buy) | D | 6,51 | 55.000 | 55.000 | |||||
| 2022-03-03 | 2022-03-01 | 4 | Milne Jill C. | ATXS | Stock Option (right to buy) | D | 6,51 | 195.000 | 195.000 | |||||
| 2022-03-03 | 2022-03-01 | 4 | Clauser Noah | ATXS | Stock Option (right to buy) | D | 6,51 | 55.000 | 55.000 | |||||
| 2022-03-03 | 2022-03-01 | 4 | Nichols Andrew John | ATXS | Stock Option (right to buy) | D | 6,51 | 55.000 | 55.000 | |||||
| 2022-03-03 | 2022-03-01 | 4 | Komjathy Andrew | ATXS | Stock Option (right to buy) | D | 6,51 | 55.000 | 55.000 | |||||
| 2022-02-10 | 2021-12-28 | 5 | Komjathy Andrew | ATXS | Common Stock | D | -45 | 10 | ||||||
| 2022-02-10 | 2021-12-28 | 5 | Komjathy Andrew | ATXS | Common Stock | D | -45 | 10 | ||||||
| 2021-11-23 | 2021-11-19 | 4 | Komjathy Andrew | ATXS | Common Stock | D | 6,6950 | 100 | 1 | 100 | ||||
| 2021-09-22 | 2021-09-20 | 4 | Violin Jonathan | ATXS | Common Stock | D | 263.321 | 263.321 | ||||||
| 2021-09-22 | 2021-09-20 | 4 | Violin Jonathan By Lazarus Life Sciences I, LLC | ATXS | Common Stock | I | -263.321 | 0 | ||||||
| 2021-06-10 | 2021-06-08 | 4 | Harshbarger Benjamin | CATB | Stock Option (right to buy) | D | 2,16 | 200.000 | 200.000 | |||||
| 2021-06-02 | 2021-06-02 | 4 | Komjathy Andrew | CATB | Stock Option (right to buy) | D | 2,87 | 600.000 | 600.000 | |||||
| 2021-06-02 | 2021-06-02 | 4 | Nichols Andrew John | CATB | Stock Option (right to buy) | D | 2,87 | 600.000 | 600.000 | |||||
| 2021-06-02 | 2021-06-02 | 4 | Violin Jonathan | CATB | Stock Option (right to buy) | D | 2,04 | 85.000 | 85.000 | |||||
| 2021-06-02 | 2021-06-02 | 4 | Callori Fred | CATB | Stock Option (right to buy) | D | 2,04 | 85.000 | 85.000 | |||||
| 2021-06-02 | 2021-06-02 | 4 | BATE KENNETH | CATB | Stock Option (right to buy) | D | 2,04 | 100.000 | 100.000 | |||||
| 2021-06-02 | 2021-06-02 | 4 | KISHBAUCH MICHAEL D | CATB | Stock Option (right to buy) | D | 2,04 | 100.000 | 100.000 | |||||
| 2021-06-02 | 2021-06-02 | 4 | Clauser Noah | CATB | Stock Option (right to buy) | D | 2,87 | 600.000 | 600.000 | |||||
| 2021-06-02 | 2021-06-02 | 4 | Cole Hugh M | CATB | Stock Option (right to buy) | D | 2,04 | 100.000 | 100.000 | |||||
| 2021-06-02 | 2021-06-02 | 4 | Milne Jill C. | CATB | Stock Option (right to buy) | D | 2,87 | 1.400.000 | 1.400.000 | |||||
| 2021-06-02 | 2021-06-02 | 4 | Beck Joanne T. | CATB | Stock Option (right to buy) | D | 2,04 | 100.000 | 100.000 | |||||
| 2021-06-02 | 2021-06-02 | 4 | Harshbarger Benjamin | CATB | Stock Option (right to buy) | D | 2,87 | 400.000 | 400.000 | |||||
| 2021-06-02 | 2021-06-02 | 4 | LAPOINTE ANTHONY GREGG | CATB | Stock Option (right to buy) | D | 2,04 | 100.000 | 100.000 | |||||
| 2021-02-03 | 2021-02-01 | 4 | PERCEPTIVE ADVISORS LLC | CATB | Series X Convertible Preferred Stock | I | 3.009,5300 | 1.617 | 4.866 | 30.920 | ||||
| 2021-02-03 | 2021-02-01 | 4 | PERCEPTIVE ADVISORS LLC | CATB | Series X Convertible Preferred Stock | I | 3.009,5300 | 4.851 | 14.599 | 4.851 | ||||
| 2021-02-03 | 3 | EDELMAN JOSEPH | CATB | Common Stock | I | 543.373 | ||||||||
| 2021-02-03 | 3 | EDELMAN JOSEPH | CATB | Common Stock | I | 1.933.551 | ||||||||
| 2021-02-03 | 2021-02-01 | 4 | Callori Fred By Perceptive Xontogeny Venture Fund, LP | CATB | Series X Convertible Preferred Stock | I | 3.009,5300 | 1.617 | 4.866 | 30.920 | ||||
| 2021-02-01 | 2021-01-28 | 4 | Violin Jonathan | CATB | Stock Option (Right to Buy) | D | 2,43 | 15.000 | 15.000 | |||||
| 2021-02-01 | 3 | Violin Jonathan By Lazarus Life Sciences I, LLC | CATB | Common Stock | I | 543.373 | ||||||||
| 2021-02-01 | 2021-01-28 | 4 | Callori Fred | CATB | Stock Option (right to buy) | D | 2,43 | 15.000 | 15.000 | |||||
| 2021-02-01 | 3 | Callori Fred By Xontogeny, LLC | CATB | Common Stock | I | 543.373 | ||||||||
| 2021-02-01 | 3 | Callori Fred By Perceptive Xontogeny Venture Fund, LP | CATB | Common Stock | I | 1.933.551 | ||||||||
| 2020-09-21 | 2020-09-17 | 4 | Clauser Noah | CATB | Stock Option (right to buy) | D | 6,94 | 35.000 | 35.000 | |||||
| 2020-06-12 | 2020-06-11 | 4 | Cole Hugh M | CATB | Stock Option (right to buy) | D | 6,17 | 7.500 | 7.500 | |||||
| 2020-06-12 | 2020-06-11 | 4 | BATE KENNETH | CATB | Stock Option (right to buy) | D | 6,17 | 7.500 | 7.500 | |||||
| 2020-06-12 | 2020-06-11 | 4 | ADELMAN BURT A | CATB | Stock Option (right to buy) | D | 6,17 | 7.500 | 7.500 | |||||
| 2020-06-12 | 2020-06-11 | 4 | LAPOINTE ANTHONY GREGG | CATB | Stock Option (right to buy) | D | 6,17 | 7.500 | 7.500 | |||||
| 2020-06-12 | 2020-06-11 | 4 | KISHBAUCH MICHAEL D | CATB | Stock Option (right to buy) | D | 6,17 | 7.500 | 7.500 | |||||
| 2020-06-12 | 2020-06-11 | 4 | Harshbarger Benjamin | CATB | Stock Option (right to buy) | D | 6,17 | 45.000 | 45.000 | |||||
| 2020-06-12 | 2020-06-11 | 4 | Beck Joanne T. | CATB | Stock Option (right to buy) | D | 6,17 | 7.500 | 7.500 | |||||
| 2020-02-14 | 2020-02-12 | 4 | Donovan Joanne M. | CATB | Stock Option (right to buy) | D | 5,32 | 60.000 | 60.000 | |||||
| 2020-02-14 | 2020-02-12 | 4 | Milne Jill C. | CATB | Stock Option (right to buy) | D | 5,32 | 150.000 | 150.000 | |||||
| 2020-02-14 | 2020-02-12 | 4 | Nichols Andrew John | CATB | Stock Option (right to buy) | D | 5,32 | 60.000 | 60.000 | |||||
| 2020-02-14 | 2020-02-12 | 4 | Komjathy Andrew | CATB | Stock Option (right to buy) | D | 5,32 | 35.000 | 35.000 | |||||
| 2020-02-14 | 2020-02-12 | 4 | Clauser Noah | CATB | Stock Option (right to buy) | D | 5,32 | 20.000 | 20.000 | |||||
| 2019-09-19 | 2019-09-18 | 4 | Komjathy Andrew | CATB | Stock Option (right to buy) | D | 5,92 | 44.500 | 44.500 | |||||
| 2019-07-30 | 2019-07-26 | 4 | Cole Hugh M | CATB | Stock Option (right to buy) | D | 6,82 | 15.000 | 15.000 | |||||
| 2019-06-05 | 2019-06-04 | 4 | BATE KENNETH | CATB | Stock Option (right to buy) | D | 6,53 | 7.500 | 7.500 | |||||
| 2019-06-05 | 2019-06-04 | 4 | ADELMAN BURT A | CATB | Stock Option (right to buy) | D | 6,53 | 7.500 | 7.500 | |||||
| 2019-06-05 | 2019-06-04 | 4 | KISHBAUCH MICHAEL D | CATB | Stock Option (right to buy) | D | 6,53 | 7.500 | 7.500 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Milne Jill C. | CATB | Stock Option (right to buy) | D | 4,39 | 100.000 | 100.000 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Donovan Joanne M. | CATB | Stock Option (right to buy) | D | 4,39 | 40.000 | 40.000 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Nichols Andrew John | CATB | Stock Option (right to buy) | D | 4,39 | 40.000 | 40.000 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Cunnane Deirdre A. | CATB | Stock Option (right to buy) | D | 4,39 | 40.000 | 40.000 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Beck Joanne T. | CATB | Stock Option (right to buy) | D | 4,39 | 15.000 | 15.000 | |||||
| 2019-02-15 | 2019-02-13 | 4 | LAPOINTE ANTHONY GREGG | CATB | Stock Option (right to buy) | D | 4,39 | 12.200 | 12.200 | |||||
| 2019-01-04 | 2019-01-03 | 4/A | LAPOINTE ANTHONY GREGG | CATB | Stock Option (right to buy) | D | 4,60 | 2.800 | 2.800 | |||||
| 2019-01-04 | 2019-01-03 | 4 | LAPOINTE ANTHONY GREGG | CATB | Stock Option (right to buy) | D | 4,90 | 2.800 | 2.800 | |||||
| 2018-09-11 | 2018-09-07 | 4 | Milne Jill C. | CATB | Stock Option (right to buy) | D | 0,71 | 230.000 | 230.000 | |||||
| 2018-09-11 | 2018-09-07 | 4 | Donovan Joanne M. | CATB | Stock Option (right to buy) | D | 0,71 | 150.000 | 150.000 | |||||
| 2018-09-11 | 2018-09-07 | 4 | Nichols Andrew John | CATB | Stock Option (right to buy) | D | 0,71 | 150.000 | 150.000 | |||||
| 2018-09-11 | 2018-09-07 | 4 | Cunnane Deirdre A. | CATB | Stock Option (right to buy) | D | 0,71 | 150.000 | 150.000 | |||||
| 2018-06-07 | 2018-06-07 | 4 | ROSS MICHAEL JAY | CATB | Stock Option (right to buy) | D | 1,48 | 14.000 | 14.000 | |||||
| 2018-06-07 | 2018-06-07 | 4 | George Jean | CATB | Stock Option (right to buy) | D | 1,48 | 14.000 | 14.000 | |||||
| 2018-06-07 | 2018-06-07 | 4 | BATE KENNETH | CATB | Stock Option (right to buy) | D | 1,48 | 14.000 | 14.000 | |||||
| 2018-06-07 | 2018-06-07 | 4 | ADELMAN BURT A | CATB | Stock Option (right to buy) | D | 1,48 | 14.000 | 14.000 | |||||
| 2018-06-07 | 2018-06-07 | 4 | KISHBAUCH MICHAEL D | CATB | Stock Option (right to buy) | D | 1,48 | 14.000 | 14.000 | |||||
| 2018-02-09 | 2018-02-08 | 4 | Hibben Edward K. | CATB | Stock Option (right to buy) | D | 1,28 | 100.000 | 100.000 | |||||
| 2018-02-09 | 2018-02-08 | 4 | Milne Jill C. | CATB | Stock Option (right to buy) | D | 1,28 | 230.000 | 230.000 | |||||
| 2018-02-09 | 2018-02-08 | 4 | Donovan Joanne M. | CATB | Stock Option (right to buy) | D | 1,28 | 100.000 | 100.000 | |||||
| 2018-02-09 | 2018-02-08 | 4 | Nichols Andrew John | CATB | Stock Option (right to buy) | D | 1,28 | 100.000 | 100.000 | |||||
| 2018-02-09 | 2018-02-08 | 4 | Cunnane Deirdre A. | CATB | Stock Option (right to buy) | D | 1,28 | 100.000 | 100.000 | |||||
| 2017-07-28 | 2017-07-27 | 4 | ADELMAN BURT A | CATB | Stock Option (right to buy) | D | 1,27 | 6.500 | 6.500 | |||||
| 2017-07-28 | 2017-07-27 | 4 | BATE KENNETH | CATB | Stock Option (right to buy) | D | 1,27 | 6.500 | 6.500 | |||||
| 2017-07-28 | 2017-07-27 | 4 | ROSS MICHAEL JAY | CATB | Stock Option (right to buy) | D | 1,27 | 6.500 | 6.500 | |||||
| 2017-07-28 | 2017-07-27 | 4 | George Jean | CATB | Stock Option (right to buy) | D | 1,27 | 6.500 | 6.500 | |||||
| 2017-07-28 | 2017-07-27 | 4 | KISHBAUCH MICHAEL D | CATB | Stock Option (right to buy) | D | 1,27 | 6.500 | 6.500 | |||||
| 2017-02-10 | 2017-02-09 | 4 | Donovan Joanne M. | CATB | Stock Option (right to buy) | D | 1,24 | 100.000 | 100.000 | |||||
| 2017-02-10 | 2017-02-09 | 4 | Milne Jill C. | CATB | Stock Option (right to buy) | D | 1,24 | 200.000 | 200.000 | |||||
| 2017-02-10 | 2017-02-09 | 4 | Cunnane Deirdre A. | CATB | Stock Option (right to buy) | D | 1,24 | 100.000 | 100.000 | |||||
| 2017-02-10 | 2017-02-09 | 4 | Nichols Andrew John | CATB | Stock Option (right to buy) | D | 1,24 | 100.000 | 100.000 | |||||
| 2016-10-05 | 2016-10-03 | 4 | Nichols Andrew John | CATB | Stock Option (right to buy) | D | 5,79 | 13.000 | 13.000 | |||||
| 2016-09-13 | 2016-09-08 | 4/A | Milne Jill C. | CATB | Stock Option (right to buy) | D | 4,31 | 45.000 | 45.000 | |||||
| 2016-09-13 | 2016-09-08 | 4/A | Donovan Joanne M. | CATB | Stock Option (right to buy) | D | 4,31 | 45.000 | 45.000 | |||||
| 2016-09-13 | 2016-09-08 | 4/A | Modi Rick | CATB | Stock Option (right to buy) | D | 4,31 | 45.000 | 45.000 | |||||
| 2016-09-13 | 2016-09-08 | 4/A | Cunnane Deirdre A. | CATB | Stock Option (right to buy) | D | 4,31 | 45.000 | 45.000 | |||||
| 2016-09-12 | 2016-09-08 | 4 | Donovan Joanne M. | CATB | Stock Option (right to buy) | D | 4,30 | 45.000 | 45.000 | |||||
| 2016-09-12 | 2016-09-08 | 4 | Modi Rick | CATB | Stock Option (right to buy) | D | 4,30 | 45.000 | 45.000 | |||||
| 2016-09-12 | 2016-09-08 | 4 | Milne Jill C. | CATB | Stock Option (right to buy) | D | 4,30 | 45.000 | 45.000 | |||||
| 2016-09-12 | 2016-09-08 | 4 | Cunnane Deirdre A. | CATB | Stock Option (right to buy) | D | 4,30 | 45.000 | 45.000 | |||||
| 2016-08-05 | 2016-08-03 | 4 | ROSS MICHAEL JAY | CATB | Stock Option (right to buy) | D | 4,55 | 6.500 | 6.500 | |||||
| 2016-08-05 | 2016-08-03 | 4 | BATE KENNETH | CATB | Stock Option (right to buy) | D | 4,55 | 6.500 | 6.500 | |||||
| 2016-08-05 | 2016-08-03 | 4 | George Jean | CATB | Stock Option (right to buy) | D | 4,55 | 6.500 | 6.500 | |||||
| 2016-08-05 | 2016-08-03 | 4 | GALAKATOS NICHOLAS | CATB | Stock Option (right to buy) | D | 4,55 | 6.500 | 6.500 | |||||
| 2016-04-07 | 2016-04-05 | 4 | ADELMAN BURT A | CATB | Stock Option (right to buy) | D | 4,80 | 13.000 | 13.000 | |||||
| 2016-04-07 | 2016-04-05 | 4 | KISHBAUCH MICHAEL D | CATB | Stock Option (right to buy) | D | 4,80 | 13.000 | 13.000 | |||||
| 2016-02-16 | 2016-02-11 | 4 | Donovan Joanne M. | CATB | Stock Option (right to buy) | D | 4,57 | 66.000 | 66.000 | |||||
| 2016-02-16 | 2016-02-11 | 4 | Sanderson Ian C. | CATB | Stock Option (right to buy) | D | 4,57 | 52.000 | 52.000 | |||||
| 2016-02-16 | 2016-02-11 | 4 | Modi Rick | CATB | Stock Option (right to buy) | D | 4,57 | 42.000 | 42.000 | |||||
| 2016-02-16 | 2016-02-11 | 4 | Milne Jill C. | CATB | Stock Option (right to buy) | D | 4,57 | 103.000 | 103.000 | |||||
| 2016-02-16 | 2016-02-11 | 4 | Cunnane Deirdre A. | CATB | Stock Option (right to buy) | D | 4,57 | 23.000 | 23.000 | |||||
| 2015-07-21 | 2015-07-17 | 4 | Milne Jill C. | CATB | Stock Option (right to buy) | D | 14,05 | 160.000 | 160.000 | |||||
| 2015-06-30 | 2015-06-30 | 4 | MedImmune Ventures, Inc. | CATB | Series B Preferred Stock | D | -4.241.780 | 0 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | MedImmune Ventures, Inc. | CATB | Series A Preferred Stock | D | -13.866.666 | 0 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | MedImmune Ventures, Inc. | CATB | Common Stock | D | 12,0000 | 223.439 | 2.681 | 1.632.652 | ||||
| 2015-06-30 | 2015-06-30 | 4 | MedImmune Ventures, Inc. | CATB | Common Stock | D | 330.098 | 1.409.213 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | MedImmune Ventures, Inc. | CATB | Common Stock | D | 1.079.115 | 1.079.115 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | ROSS MICHAEL JAY | CATB | Stock Option (right to buy) | D | 12,21 | 11.094 | 11.094 | |||||
| 2015-06-30 | 2015-06-30 | 4 | BATE KENNETH | CATB | Stock Option (right to buy) | D | 12,21 | 11.094 | 11.094 | |||||
| 2015-06-30 | 2015-06-30 | 4 | Clarus Lifesciences II, L.P. | CATB | Series B Preferred Stock | D | -9.728.971 | 0 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | Clarus Lifesciences II, L.P. | CATB | Series A Preferred Stock | D | -20.800.000 | 0 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | Clarus Lifesciences II, L.P. | CATB | Common Stock | D | 12,0000 | 376.695 | 4.520 | 2.752.488 | ||||
| 2015-06-30 | 2015-06-30 | 4 | Clarus Lifesciences II, L.P. | CATB | Common Stock | D | 757.117 | 2.375.793 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | Clarus Lifesciences II, L.P. | CATB | Common Stock | D | 1.618.676 | 1.618.676 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | GALAKATOS NICHOLAS | CATB | Stock Option (right to buy) | D | 12,21 | 11.094 | 11.094 | |||||
| 2015-06-30 | 2015-06-30 | 4 | GALAKATOS NICHOLAS See Footnotes | CATB | Series B Preferred Stock | I | -9.728.971 | 0 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | GALAKATOS NICHOLAS See Footnotes | CATB | Series A Preferred Stock | I | -20.800.000 | 0 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | GALAKATOS NICHOLAS See Footnotes | CATB | Common Stock | I | 12,0000 | 376.695 | 4.520 | 2.752.488 | ||||
| 2015-06-30 | 2015-06-30 | 4 | GALAKATOS NICHOLAS See Footnotes | CATB | Common Stock | I | 757.117 | 2.375.793 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | GALAKATOS NICHOLAS See Footnotes | CATB | Common Stock | I | 1.618.676 | 1.618.676 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | George Jean | CATB | Stock Option (right to buy) | D | 12,21 | 11.094 | 11.094 | |||||
| 2015-06-30 | 2015-06-30 | 4 | George Jean | CATB | Series B Preferred Stock | I | -1.006.712 | 0 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | George Jean | CATB | Series B Preferred Stock | I | -7.388.491 | 0 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | George Jean | CATB | Series B Preferred Stock | I | -3.910.392 | 0 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | George Jean | CATB | Series A Preferred Stock | I | -8.666.667 | 0 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | George Jean | CATB | Common Stock | I | 12,0000 | 12.422 | 149 | 90.764 | ||||
| 2015-06-30 | 2015-06-30 | 4 | George Jean | CATB | Common Stock | I | 12,0000 | 91.166 | 1.094 | 666.145 | ||||
| 2015-06-30 | 2015-06-30 | 4 | George Jean | CATB | Common Stock | I | 12,0000 | 155.188 | 1.862 | 1.133.943 | ||||
| 2015-06-30 | 2015-06-30 | 4 | George Jean | CATB | Common Stock | I | 78.342 | 78.342 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | George Jean | CATB | Common Stock | I | 574.979 | 574.979 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | George Jean | CATB | Common Stock | I | 304.309 | 978.755 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | George Jean | CATB | Common Stock | I | 674.446 | 674.446 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | Jirousek Michael | CATB | Series B Preferred Stock | D | -5.261 | 0 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | Jirousek Michael | CATB | Series A Preferred Stock | D | -856.571 | 0 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | Jirousek Michael | CATB | Common Stock | D | 409 | 246.093 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | Jirousek Michael | CATB | Common Stock | D | 66.658 | 245.684 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | Donovan Joanne M. | CATB | Series B Preferred Stock | D | -5.261 | 0 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | Donovan Joanne M. | CATB | Common Stock | D | 409 | 409 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | Modi Rick | CATB | Series B Preferred Stock | D | -52.614 | 0 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | Modi Rick | CATB | Common Stock | D | 4.094 | 4.094 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | SVLSF V, LLC See Footnotes | CATB | Series B Preferred Stock | I | -207.558 | 0 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | SVLSF V, LLC See Footnotes | CATB | Series B Preferred Stock | I | -9.821.385 | 0 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | SVLSF V, LLC See Footnotes | CATB | Series A Preferred Stock | I | -448.414 | 0 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | SVLSF V, LLC See Footnotes | CATB | Series A Preferred Stock | I | -21.218.253 | 0 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | SVLSF V, LLC See Footnotes | CATB | Common Stock | I | 12,0000 | 8.094 | 97 | 59.139 | ||||
| 2015-06-30 | 2015-06-30 | 4 | SVLSF V, LLC See Footnotes | CATB | Common Stock | I | 12,0000 | 382.996 | 4.596 | 2.798.528 | ||||
| 2015-06-30 | 2015-06-30 | 4 | SVLSF V, LLC See Footnotes | CATB | Common Stock | I | 16.152 | 51.045 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | SVLSF V, LLC See Footnotes | CATB | Common Stock | I | 764.309 | 2.415.532 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | SVLSF V, LLC See Footnotes | CATB | Common Stock | I | 34.893 | 34.893 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | SVLSF V, LLC See Footnotes | CATB | Common Stock | I | 1.651.223 | 1.651.223 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | Milne Jill C. | CATB | Series B Preferred Stock | D | -105.229 | 0 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | Milne Jill C. | CATB | Series A Preferred Stock | D | -856.548 | 0 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | Milne Jill C. | CATB | Common Stock | D | 8.189 | 253.872 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | Milne Jill C. | CATB | Common Stock | D | 66.657 | 245.683 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | Laufer Ron | CATB | Stock Option (right to buy) | D | 12,21 | 11.094 | 11.094 | |||||
| 2015-06-30 | 2015-06-30 | 4 | Laufer Ron | CATB | Series B Preferred Stock | I | -4.241.780 | 0 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | Laufer Ron | CATB | Series A Preferred Stock | I | -13.866.666 | 0 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | Laufer Ron | CATB | Common Stock | I | 12,0000 | 223.439 | 2.681 | 1.632.652 | ||||
| 2015-06-30 | 2015-06-30 | 4 | Laufer Ron | CATB | Common Stock | I | 330.098 | 1.409.213 | ||||||
| 2015-06-30 | 2015-06-30 | 4 | Laufer Ron | CATB | Common Stock | I | 1.079.115 | 1.079.115 | ||||||
| 2015-06-24 | 3 | Jirousek Michael | CATB | Common Stock | D | 358.052 | ||||||||
| 2015-06-24 | 3 | Jirousek Michael | CATB | Common Stock | D | 358.052 | ||||||||
| 2015-06-24 | 3 | Milne Jill C. | CATB | Common Stock | D | 358.052 | ||||||||
| 2015-06-24 | 3 | Milne Jill C. | CATB | Common Stock | D | 358.052 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
